Fougera to market generic Clindamycin Phosphate Lotion
Wednesday, February 06, 2002 08:00 IST New York
Fougera, a division of Altana Inc, has received FDA approval to market generic Clindamycin Phosphate Lotion (Clindamycin Phosphate Topical Suspension USP, 1%) (RX). Fougera will be the first company to market with this generic formulation.